Brind.

FDA granted 510(k) clearance for the ClearPoint Prism Neuro Laser Therapy System, allowing it to be used with 1.5T MRI guidance.

5 reports, 2 independent Updated Oct 14
Gone quiet
Reports
5
Developments
2
Repetition
60%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

FDA granted 510(k) clearance for the ClearPoint Prism Neuro Laser Therapy System, allowing it to be used with 1.5T MRI guidance.

Who's involved

What this event is mainly about
ClearPoint Neuro (United States)FDA

How it developed

Newest first. Tap a step to see who reported it.
  1. The company confirmed its global presence and Nasdaq listing alongside its FDA-cleared product.1 source
  2. ClearPoint Neuro received FDA 510(k) clearance for its neuro laser system.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • pr-inside.com
  • ACCESS NewswireClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 4, 20
  • ACCESS NewswireClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025 SOLANA BEACH, CALIFORNIA / ACCESS Newswire / July 23, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global de
2 more outlets ran the same wire story